Albuterol/Budesonide Reduces Risk of Severe Exacerbation in Patients With Asthma
Positive high-level results from the phase 3b BATURA clinical trial (NCT05505734) indicate that compared with as-needed albuterol, albuterol/budesonide (formerly PT027, Airsupra; AstraZeneca) demonstrated a statistically significant and clinically …